Literature DB >> 22513282

Synthesis and anti-norovirus activity of pyranobenzopyrone compounds.

Laxman Pokhrel1, Yunjeong Kim, Thi D T Nguyen, Allan M Prior, Jianyu Lu, Kyeong-Ok Chang, Duy H Hua.   

Abstract

During the last decade, noroviruses have gained media attention as the cause of large scale outbreaks of gastroenteritis on cruise ships, dormitories, nursing homes, etc. Although noroviruses do not multiply in food or water, they can cause large outbreaks because approximately 10-100 virions are sufficient to cause illness in a healthy adult. Recently, it was shown that the activity of acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1) enzyme may be important in norovirus infection. In search of anti-noroviral agents based on the inhibition of ACAT1, we synthesized and evaluated the inhibitory activities of a class of pyranobenzopyrone molecules containing amino, pyridine, substituted quinolines, or 7,8-benzoquinoline nucleus. Three of the sixteen evaluated compounds possess ED(50) values in the low micrometer range. 2-Quinolylmethyl derivative 3A and 4-quinolylmethyl derivative 4A showed ED(50) values of 3.4 and 2.4 μM and TD(50) values of >200 and 96.4 μM, respectively. The identified active compounds are suitable for further modification for the development of anti-norovirus agents.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513282      PMCID: PMC3348348          DOI: 10.1016/j.bmcl.2012.03.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections.

Authors:  Mohammed A Fakhfakh; Alain Fournet; Eric Prina; Jean-François Mouscadet; Xavier Franck; Reynald Hocquemiller; Bruno Figadère
Journal:  Bioorg Med Chem       Date:  2003-11-17       Impact factor: 3.641

2.  A new family of quinoline and quinoxaline analogues of combretastatins.

Authors:  Concepción Pérez-Melero; Ana B S Maya; Benedicto del Rey; Rafael Peláez; Esther Caballero; Manuel Medarde
Journal:  Bioorg Med Chem Lett       Date:  2004-07-16       Impact factor: 2.823

3.  Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Iodine(V) reagents in organic synthesis. Part 4. o-Iodoxybenzoic acid as a chemospecific tool for single electron transfer-based oxidation processes.

Authors:  K C Nicolaou; T Montagnon; P S Baran; Y-L Zhong
Journal:  J Am Chem Soc       Date:  2002-03-13       Impact factor: 15.419

5.  Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line.

Authors:  Kyeong-Ok Chang; Stanislav V Sosnovtsev; Gaël Belliot; Adriene D King; Kim Y Green
Journal:  Virology       Date:  2006-07-14       Impact factor: 3.616

6.  Role of cholesterol pathways in norovirus replication.

Authors:  Kyeong-Ok Chang
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Human susceptibility and resistance to Norwalk virus infection.

Authors:  Lisa Lindesmith; Christine Moe; Severine Marionneau; Nathalie Ruvoen; Xi Jiang; Lauren Lindblad; Paul Stewart; Jacques LePendu; Ralph Baric
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

9.  Norovirus and foodborne disease, United States, 1991-2000.

Authors:  Marc-Alain Widdowson; Alana Sulka; Sandra N Bulens; R Suzanne Beard; Sandra S Chaves; Roberta Hammond; Ellen D P Salehi; Ellen Swanson; Jessica Totaro; Ray Woron; Paul S Mead; Joseph S Bresee; Stephan S Monroe; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

  9 in total
  14 in total

1.  Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines.

Authors:  Jianyu Lu; Izumi Maezawa; Sahani Weerasekara; Ramazan Erenler; Tuyen D T Nguyen; James Nguyen; Luxi Z Swisher; Jun Li; Lee-Way Jin; Alok Ranjan; Sanjay K Srivastava; Duy H Hua
Journal:  Bioorg Med Chem Lett       Date:  2014-06-04       Impact factor: 2.823

Review 2.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

3.  Structural and inhibitor studies of norovirus 3C-like proteases.

Authors:  Daisuke Takahashi; Yunjeong Kim; Scott Lovell; Om Prakash; William C Groutas; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2013-09-17       Impact factor: 3.303

4.  Inhibition of Acyl-CoA: cholesterol acyltransferase (ACAT), overexpression of cholesterol transporter gene, and protection of amyloid β (Aβ) oligomers-induced neuronal cell death by tricyclic pyrone molecules.

Authors:  Laxman Pokhrel; Izumi Maezawa; Thi D T Nguyen; Kyeong-Ok Chang; Lee-Way Jin; Duy H Hua
Journal:  J Med Chem       Date:  2012-10-05       Impact factor: 7.446

5.  Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Anushka C Galasiti Kankanamalage; Roxanne Adeline Z Uy; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2013-08-22       Impact factor: 2.823

Review 6.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

Review 7.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

8.  Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Kok-Chuan Tiew; Roxanne Adeline Z Uy; Allan M Prior; Kevin R Alliston; Duy H Hua; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-11-21       Impact factor: 2.823

9.  Syntheses of 3-[(Alkylamino)methylene]-6-methylpyridine-2,4(1H,3H)-diones, 3-Substituted 7-Methyl-2H-pyrano[3,2-c]pyridine-2,5(6H)-dione Fluorescence Probes, and Tetrahydro-1H,9H-2,10-dioxa-9-azaanthracen-1-ones.

Authors:  Allan M Prior; Medha J Gunaratna; Daisuke Kikuchi; John Desper; Yunjeong Kim; Kyeong-Ok Chang; Izumi Maezawa; Lee-Way Jin; Duy H Hua
Journal:  Synthesis (Stuttg)       Date:  2014-08       Impact factor: 3.157

Review 10.  Anti-norovirus therapeutics: a patent review (2010-2015).

Authors:  Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.